• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » WCCT Global successfully completes enrollment in ethnobridging study

WCCT Global successfully completes enrollment in ethnobridging study

February 11, 2013
CenterWatch Staff

WCCT Global, a global CRO supporting phase I-IV bio-pharmaceutical and device development, announced the success of their specialized recruitment methods for ethnobridging studies.

The company has over 10 years of experience in Asian bridging studies. Its geographic location in Southern California has played a major role in enabling it to recruit qualified participants for Asian Bridging Studies. Their volunteer database includes potential volunteers of Japanese, Chinese, Taiwanese, Asian Indian, Korean and Philippine decent and has grown to be quite extensive and very valuable asset.

WCCT Global was recently chosen to recruit and conduct a very difficult Japanese special population study with very stringent inclusion and exclusion criteria. By utilizing its database in combination with their proprietary, multi-media tools were able to successfully enroll and execute the study ahead of schedule for the sponsor.

WCCT Global has carried out over 60 ethnobridging clinical trials and recruited over 1,200 Asian volunteers since 1993. The recruitment methods that WCCT Global has developed have become such a robust tool for special population studies that sponsors around the world reach out to WCCT Global to help recruit and execute a diverse panel of clinical studies.

The company has released a five-part video series on "The Role of Ethnic Bridging in Enhancing Asset Value and Accelerating Global Drug Development." This video series is to inform sponsors on the importance of developing drugs for the global market.

“We wanted to share some of the knowledge we have gained in this field over the years in order to help sponsors accelerate patient access to new medical treatments, globally,” said Mel Affrime, senior vice president, R&D, WCCT Global.

Upcoming Events

  • 26Jan

    Reducing Complexity in Starting Clinical Trials – More Patients, Faster Startup

  • 27Jan

    Medical Device Clinical Trials in China: Latest Regulatory Developments

  • 11Feb

    Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • TechInnovation-360x240.png

    Pace of Technology Innovation in Trials Could Slow After Pandemic Eases

  • AskTheExperts-360x240.png

    Ask the Experts: Certifying and Maintaining Copies of Original Source Documents

  • Resources-360x240.png

    Trial Complexity, Endpoints Continue to Increase, Stretching Site Resources

  • FocusinRed-360x240.png

    Return to Focus on Risk Management Postpandemic Could Prove Challenging to Sites

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing